Msdi, Abdulwhab Shremo https://orcid.org/0009-0009-1582-0611
Ravari, Alireza Fakhri
Abdul-Mutakabbir, Jacinda C.
Tan, Karen K.
Article History
Received: 18 November 2024
Accepted: 31 January 2025
First Online: 17 February 2025
Declarations
:
: Jacinda Abdul-Mutakabbir is an Advisory Board member of Infectious Diseases and Therapy. Jacinda Abdul-Mutakabbir was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Jacinda Abdul-Mutakabbir received an honorarium from Shionogi, GSK, NovaVax, and CSL Sequiris. She has also received research support from CSL Sequiris. All other authors (Abdulwhab Shremo Msdi and Karen K. Tan) have no conflicts to report.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration. The LLUMC Institutional Review Board approved this study (#5210270) and the waiver of informed consent, given the minimal risk and retrospective nature of the study design.